These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32229515)

  • 1. OCT-A characterisation of recurrent type 3 macular neovascularisation.
    Sacconi R; Battista M; Borrelli E; Miere A; Corbelli E; Capuano V; Querques L; Souied EH; Bandello F; Querques G
    Br J Ophthalmol; 2021 Feb; 105(2):222-226. PubMed ID: 32229515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spectral-Domain Optical Coherence Tomography Analysis of Fibrotic Lesions in Neovascular Age-Related Macular Degeneration.
    Souied EH; Addou-Regnard M; Ohayon A; Semoun O; Querques G; Blanco-Garavito R; Bunod R; Jung C; Sikorav A; Miere A
    Am J Ophthalmol; 2020 Jun; 214():151-171. PubMed ID: 32112774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUB-RETINAL PIGMENT EPITHELIUM MULTILAMINAR HYPERREFLECTIVITY AT THE ONSET OF TYPE 3 MACULAR NEOVASCULARIZATION.
    Miere A; Sacconi R; Amoroso F; Capuano V; Jung C; Bandello F; Souied EH; Querques G
    Retina; 2021 Jan; 41(1):135-143. PubMed ID: 32282662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
    Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with the development of exudation in treatment-naive eyes with nonexudative macular neovascularization.
    Cho HJ; Kim M; Kim J; Yoon I; Park S; Kim CG
    Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2073-2082. PubMed ID: 38349420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic Correlation of Anti-Vascular Endothelial Growth Factor-Treated Type 3 Neovascularization in Age-Related Macular Degeneration.
    Li M; Dolz-Marco R; Messinger JD; Wang L; Feist RM; Girkin CA; Gattoussi S; Ferrara D; Curcio CA; Freund KB
    Ophthalmology; 2018 Feb; 125(2):276-287. PubMed ID: 28964579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OCT Risk Factors for Development of Late Age-Related Macular Degeneration in the Fellow Eyes of Patients Enrolled in the HARBOR Study.
    Nassisi M; Lei J; Abdelfattah NS; Karamat A; Balasubramanian S; Fan W; Uji A; Marion KM; Baker K; Huang X; Morgenthien E; Sadda SR
    Ophthalmology; 2019 Dec; 126(12):1667-1674. PubMed ID: 31281056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOUBLE RETINAL PIGMENT EPITHELIUM TEARS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Mouallem A; Sarraf D; Chen X; Capuano V; Souied EH; Querques G
    Retina; 2016 Nov; 36(11):2197-2204. PubMed ID: 27145251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can objective parameters in optical coherence tomography be useful markers in the treatment and follow-up of type 1 and type 2 macular neovascularizations related to neovascular age-related macular degeneration?
    Özen O; Koçak Altıntaş AG
    Int Ophthalmol; 2024 Mar; 44(1):134. PubMed ID: 38483688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonexudative Macular Neovascularization Supporting Outer Retina in Age-Related Macular Degeneration: A Clinicopathologic Correlation.
    Chen L; Messinger JD; Sloan KR; Swain TA; Sugiura Y; Yannuzzi LA; Curcio CA; Freund KB
    Ophthalmology; 2020 Jul; 127(7):931-947. PubMed ID: 32247535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROGRESSION OF MACULAR ATROPHY IN EYES WITH TYPE 1 NEOVASCULARIZATION AND AGE-RELATED MACULAR DEGENERATION RECEIVING LONG-TERM INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY: An Optical Coherence Tomographic Angiography Analysis.
    Christenbury JG; Phasukkijwatana N; Gilani F; Freund KB; Sadda S; Sarraf D
    Retina; 2018 Jul; 38(7):1276-1288. PubMed ID: 28723848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-Year Risk of Exudation in Eyes with Nonexudative Age-Related Macular Degeneration and Subclinical Neovascularization Detected with Swept Source Optical Coherence Tomography Angiography.
    Yang J; Zhang Q; Motulsky EH; Thulliez M; Shi Y; Lyu C; de Sisternes L; Durbin MK; Feuer W; Wang RK; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2019 Dec; 208():1-11. PubMed ID: 31229464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal anti-VEGF therapy for vascularized pigment epithelium detachment in age-related macular degeneration.
    Giansanti F; Bacherini D; Giacomelli G; Virgili G; Finocchio L; Fiore T; Vannozzi L; Menchini U
    Eur J Ophthalmol; 2014; 24(3):402-8. PubMed ID: 24242217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of macular neovascularisation in geographic atrophy.
    Sacconi R; Brambati M; Miere A; Costanzo E; Capuano V; Borrelli E; Battista M; Parravano M; Souied EH; Bandello F; Querques G
    Br J Ophthalmol; 2022 Sep; 106(9):1282-1287. PubMed ID: 33836986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of retinal pigment epithelium tear formation following intravitreal anti-vascular endothelial growth factor therapy revealed by spectral-domain optical coherence tomography.
    Nagiel A; Freund KB; Spaide RF; Munch IC; Larsen M; Sarraf D
    Am J Ophthalmol; 2013 Nov; 156(5):981-988.e2. PubMed ID: 23972309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.